1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39:165–228.
Article
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29:1303–10.
Article
3. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005; 365:63–78.
Article
4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348:1546–54.
Article
5. Wang HE, Shapiro N, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007; 35:1928–36.
Article
6. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med. 2001; 29:1303–10.
Article
7. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32:858–73.
Article
8. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008; 34:17–60.
Article
10. Honselmann KC, Buthut F, Heuwer B, Karadag S, Sayk F, Kurowski V, et al. Long-term mortality and quality of life in intensive care patients treatedfor pneumonia and/or sepsis, predictors of mortality and quality of life in patients with sepsis/pneumonia. J Crit care. 2015; 30:721–6.
11. Halm EA, Teirstein AS. Clinical practice. Management of community-acquired pneumonia. N Engl J Med. 2002; 347:2039–45.
12. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care. 2006; 10:R42.
13. Brun-Buisson C, Meshaka P, Pinton P, Vallet B; EPISEPSIS Study Group. EPISEPSIS : a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004; 30:580–8.
14. Capp R, Horton CL, Takhar SS, Ginde AA, Peak DA, Zane R, et al. Predictors of patients who present to the emergency department with sepsis and progress to septic shock between 4 and 48 hours of emergency department arrival. Crit Care Med. 2015; 43:983–8.
Article
15. Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, et al. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med. 2005; 33:952–61.
Article
16. Lee YW, Jung JW, Song JH, Jeon EJ, Choi JC, Shin JW, et al. Risk factors for mortality in community-acquired pneumonia patients admitted to a Referral Hospital. Tuberc Respir Dis. 2006; 61:347–55.
Article
17. Park HP, Seo YW, Lee JE, Kim YH, Jang YY, Park SH, et al. Factors associated with early death in patients with community-acquired pneumonia. Tuberc Respir Dis. 2005; 58:607–13.
Article
18. Richards G, Levy H, Laterre PF, Feldman C, Woodward B, Bates BM, et al. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 2011; 26:34–40.
Article
19. Bohnen JMA, Mustard RA, Oxholm SE, Schouten D. APACHI II Score and Abdominal Sepsis: a prospective study. Arch Surg. 1988; 123:225–29.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHI II: a severity of disease classification system. Crit Care Med. 1985; 13:818–29.
21. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006; 34:15–21.
Article
22. Kale SS, Yende S. Effects of aging on inflammation and hemostasis through the continuum of critical illness. Aging Dis. 2011; 2:501–11.
23. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005; 41 Suppl 7:S504–12.
Article
24. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/AmericanThoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. CID. 2007; 44(Suppl 2):S27–72.
25. ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370:1683–93.
Article
26. Gu WJ, Wang F, Bakker J, Tang L, Liu JC. The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials. Crit Care. 2014; 18:570.
Article
27. Shin HJ, Lee KH, Hwang SO, Kim H, Shin TY, Kim SC. The efficacy of early goal-directed therapy in septic shock patients in the emergency department: severe sepsis campaign. Korean J Crit Care Med. 2010; 25:61–70.
Article
28. Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med. 2015; 43:1907–15.
29. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically Ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014; 311:1308–16.
Article